---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-251240"
form_type: "8-K"
ticker: "ANTX"
cik: "0001880438"
company_name: "AN2 Therapeutics, Inc."
filed_at: "2024-11-05T23:59:59+00:00"
generated_at: "2026-05-30T05:29:45.657772+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# AN2 Therapeutics appoints Joshua Eizen as Chief Legal Officer and COO

## Summary
- Joshua Eizen appointed Chief Legal Officer and Chief Operating Officer effective Nov 4, 2024.
- Salary increased to $450,000; granted option for 63,000 shares and 31,500 RSUs.
- Option vests monthly over 48 months; RSUs vest annually over 4 years.
- Eizen previously served as Chief Legal Counsel; no family relationships or related-party transactions.

## SEC filing metadata
- accession: 0001193125-24-251240
- form_type: 8-K
- ticker: ANTX
- cik: 0001880438
- company_name: AN2 Therapeutics, Inc.
- filed_at: 2024-11-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1880438/000119312524251240/0001193125-24-251240-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1880438/000119312524251240/d872811d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-251240
- JSON: https://secwatch.observer/filing/0001193125-24-251240.json
- Plain text: https://secwatch.observer/filing/0001193125-24-251240.txt

## Key facts
- Executive change
  Joshua Eizen was appointed as Chief Legal Officer and Chief Operating Officer at AN2 Therapeutics, Inc..
  - Action: appointed
  - Role: Chief Legal Officer and Chief Operating Officer
  source text: On November 4, 2024, the Board of Directors of AN2 Therapeutics, Inc. (the “Company”) appointed Joshua Eizen, the Company’s current Chief Legal Counsel, age 47, as Chief Legal Officer and Chief Operating Officer of the Company, effective immediately
  evidence_url: https://www.sec.gov/Archives/edgar/data/1880438/000119312524251240/0001193125-24-251240-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.